| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.916 | 0.003 | 0.916 | Antiadrenergic | 0.727 0.004 DBMET00268 0.896 0.004 DBMET00310 0.209 0.023 DBMET02586 0.218 0.021 DBMET02587 | ||
| 0.915 | 0.003 | 0.915 | Adrenaline antagonist | 0.725 0.004 DBMET00268 0.895 0.004 DBMET00310 0.206 0.022 DBMET02586 0.216 0.021 DBMET02587 | ||
| 0.757 | 0.005 | 0.757 | Cardiotonic | 0.63 0.006 DBMET00268 0.722 0.005 DBMET00310 0.419 0.026 DBMET02586 0.485 0.017 DBMET02587 | ||
| 0.738 | 0.005 | 0.776 | Spasmolytic | 0.59 0.014 DBMET00268 0.776 0.004 DBMET00310 0.665 0.008 DBMET02586 0.324 0.061 DBMET02587 | DBMET00310 | |
| 0.729 | 0.005 | 0.729 | Vasodilator, peripheral | 0.555 0.02 DBMET00268 0.721 0.005 DBMET00310 0.641 0.011 DBMET02586 0.663 0.009 DBMET02587 | ||
| 0.695 | 0.007 | 0.695 | 5 Hydroxytryptamine release stimulant | 0.628 0.012 DBMET00268 0.695 0.007 DBMET00310 0.449 0.036 DBMET02586 0.389 0.048 DBMET02587 | ||
| 0.684 | 0.005 | 0.806 | Vasodilator, coronary | 0.473 0.019 DBMET00268 0.701 0.005 DBMET00310 0.806 0.004 DBMET02586 0.458 0.022 DBMET02587 | DBMET02586 | |
| 0.658 | 0.012 | 0.781 | Aldehyde oxidase inhibitor | 0.705 0.008 DBMET00268 0.734 0.006 DBMET00310 0.781 0.005 DBMET02587 | DBMET02587 | |
| 0.627 | 0.002 | 0.633 | Beta adrenoreceptor antagonist | 0.26 0.003 DBMET00268 0.633 0.002 DBMET00310 0.093 0.019 DBMET02586 0.152 0.006 DBMET02587 | DBMET00310 | |
| 0.613 | 0.004 | 0.613 | Anesthetic local | 0.375 0.008 DBMET00268 0.577 0.004 DBMET00310 0.187 0.036 DBMET02587 | ||
| 0.552 | 0.008 | 0.559 | Vasodilator | 0.416 0.02 DBMET00268 0.559 0.008 DBMET00310 0.526 0.01 DBMET02586 0.364 0.03 DBMET02587 | DBMET00310 | |
| 0.559 | 0.018 | 0.647 | 5 Hydroxytryptamine release inhibitor | 0.599 0.011 DBMET00268 0.519 0.027 DBMET00310 0.503 0.031 DBMET02586 0.647 0.006 DBMET02587 | DBMET02587 | |
| 0.507 | 0.002 | 0.517 | Beta 2 adrenoreceptor antagonist | 0.223 0.003 DBMET00268 0.517 0.002 DBMET00310 0.065 0.02 DBMET02586 0.104 0.007 DBMET02587 | DBMET00310 | |
| 0.501 | 0.002 | 0.501 | Beta 1 adrenoreceptor antagonist | 0.226 0.003 DBMET00268 0.493 0.002 DBMET00310 0.056 0.04 DBMET02586 0.126 0.006 DBMET02587 | ||
| 0.534 | 0.048 | 0.64 | Caspase 9 stimulant | 0.532 0.049 DBMET00268 0.64 0.031 DBMET00310 0.514 0.055 DBMET02586 0.536 0.048 DBMET02587 | DBMET00310 | |
| 0.501 | 0.032 | 0.677 | Cholesterol antagonist | 0.503 0.032 DBMET00268 0.49 0.034 DBMET00310 0.677 0.01 DBMET02586 0.652 0.012 DBMET02587 | DBMET02586 | |
| 0.466 | 0.01 | 0.466 | P-glycoprotein inhibitor | 0.42 0.014 DBMET00268 0.462 0.011 DBMET00310 0.228 0.049 DBMET02586 0.349 0.021 DBMET02587 | ||
| 0.449 | 0.002 | 0.458 | Beta 3 adrenoreceptor antagonist | 0.196 0.004 DBMET00268 0.458 0.002 DBMET00310 0.065 0.043 DBMET02586 0.158 0.005 DBMET02587 | DBMET00310 | |
| 0.454 | 0.007 | 0.454 | Sodium/bile acid cotransporter inhibitor | 0.396 0.018 DBMET00268 0.452 0.007 DBMET00310 0.386 0.022 DBMET02586 0.412 0.014 DBMET02587 | ||
| 0.482 | 0.035 | 0.644 | Histamine release inhibitor | 0.541 0.018 DBMET00268 0.517 0.023 DBMET00310 0.539 0.018 DBMET02586 0.644 0.007 DBMET02587 | DBMET02587 | |
| 0.456 | 0.01 | 0.465 | Cyclic AMP phosphodiesterase inhibitor | 0.344 0.027 DBMET00268 0.465 0.009 DBMET00310 0.421 0.014 DBMET02586 0.332 0.03 DBMET02587 | DBMET00310 | |
| 0.443 | 0.003 | 0.472 | Adrenaline agonist | 0.235 0.005 DBMET00268 0.472 0.002 DBMET00310 0.073 0.067 DBMET02586 0.152 0.014 DBMET02587 | DBMET00310 | |
| 0.476 | 0.043 | 0.476 | Antiobesity | 0.219 0.188 DBMET00268 0.41 0.062 DBMET00310 0.309 0.11 DBMET02586 0.423 0.057 DBMET02587 | ||
| 0.422 | 0.004 | 0.422 | Nav1.3 sodium channel blocker | 0.221 0.019 DBMET00268 0.373 0.005 DBMET00310 0.146 0.05 DBMET02587 | ||
| 0.472 | 0.059 | 0.756 | Cyclophilin D inhibitor | 0.474 0.058 DBMET00268 0.471 0.059 DBMET00310 0.674 0.017 DBMET02586 0.756 0.009 DBMET02587 | DBMET02587 | |
| 0.411 | 0.021 | 0.449 | Psychostimulant | 0.263 0.054 DBMET00268 0.449 0.016 DBMET00310 0.294 0.044 DBMET02586 0.168 0.102 DBMET02587 | DBMET00310 | |
| 0.422 | 0.044 | 0.756 | Antithrombotic | 0.355 0.063 DBMET00268 0.43 0.042 DBMET00310 0.756 0.005 DBMET02586 0.454 0.037 DBMET02587 | DBMET02586 | |
| 0.375 | 0.008 | 0.436 | Insulin sensitizer | 0.347 0.009 DBMET00268 0.384 0.007 DBMET00310 0.237 0.043 DBMET02586 0.436 0.005 DBMET02587 | DBMET02587 | |
| 0.373 | 0.011 | 0.421 | DNA methyltransferase I inhibitor | 0.253 0.046 DBMET00268 0.421 0.008 DBMET00310 0.35 0.014 DBMET02586 0.279 0.034 DBMET02587 | DBMET00310 | |
| 0.365 | 0.014 | 0.415 | DNA methylase inhibitor | 0.273 0.037 DBMET00268 0.414 0.01 DBMET00310 0.415 0.01 DBMET02586 0.257 0.044 DBMET02587 | DBMET02586 | |
| 0.35 | 0.012 | 0.572 | Alpha-N-acetylglucosaminidase inhibitor | 0.271 0.02 DBMET00268 0.332 0.013 DBMET00310 0.454 0.007 DBMET02586 0.572 0.004 DBMET02587 | DBMET02587 | |
| 0.311 | 0.011 | 0.334 | Insulin secretagoues | 0.292 0.013 DBMET00268 0.301 0.012 DBMET00310 0.274 0.016 DBMET02586 0.334 0.009 DBMET02587 | DBMET02587 | |
| 0.37 | 0.071 | 0.693 | Transcription factor NF kappa B inhibitor | 0.286 0.103 DBMET00268 0.456 0.052 DBMET00310 0.693 0.021 DBMET02586 0.283 0.105 DBMET02587 | DBMET02586 | |
| 0.295 | 0.005 | 0.295 | Calcium antagonist | 0.227 0.01 DBMET00268 0.256 0.008 DBMET00310 0.162 0.019 DBMET02587 | ||
| 0.323 | 0.033 | 0.521 | Peroxidase inhibitor | 0.494 0.01 DBMET00268 0.429 0.017 DBMET00310 0.521 0.008 DBMET02587 | DBMET02587 | |
| 0.331 | 0.043 | 0.574 | Hypoglycemic | 0.386 0.03 DBMET00268 0.37 0.033 DBMET00310 0.574 0.01 DBMET02586 0.546 0.012 DBMET02587 | DBMET02586 | |
| 0.317 | 0.037 | 0.334 | 5 Hydroxytryptamine uptake stimulant | 0.259 0.072 DBMET00268 0.334 0.031 DBMET00310 0.25 0.081 DBMET02587 | DBMET00310 | |
| 0.321 | 0.05 | 0.433 | DNA damaging | 0.433 0.022 DBMET00268 0.351 0.041 DBMET00310 0.314 0.052 DBMET02586 0.227 0.095 DBMET02587 | DBMET00268 | |
| 0.271 | 0.002 | 0.31 | Beta adrenoreceptor agonist | 0.079 0.004 DBMET00268 0.31 0.002 DBMET00310 0.046 0.027 DBMET02586 0.06 0.008 DBMET02587 | DBMET00310 | |
| 0.285 | 0.017 | 0.332 | Interleukin 6 antagonist | 0.332 0.011 DBMET00268 0.283 0.017 DBMET00310 0.185 0.051 DBMET02586 0.235 0.026 DBMET02587 | DBMET00268 | |
| 0.3 | 0.033 | 0.3 | Gastrin inhibitor | 0.226 0.111 DBMET00268 0.286 0.044 DBMET00310 0.233 0.101 DBMET02586 0.295 0.036 DBMET02587 | ||
| 0.311 | 0.048 | 0.343 | Transcription factor STAT3 inhibitor | 0.313 0.047 DBMET00268 0.34 0.036 DBMET00310 0.343 0.035 DBMET02587 | DBMET02587 | |
| 0.303 | 0.046 | 0.449 | Interleukin agonist | 0.344 0.031 DBMET00268 0.291 0.052 DBMET00310 0.449 0.013 DBMET02586 0.345 0.03 DBMET02587 | DBMET02586 | |
| 0.244 | 0.004 | 0.25 | Adenylate cyclase stimulant | 0.221 0.007 DBMET00268 0.25 0.004 DBMET00310 0.172 0.033 DBMET02586 0.213 0.009 DBMET02587 | DBMET00310 | |
| 0.324 | 0.101 | 0.51 | Immunosuppressant | 0.307 0.111 DBMET00268 0.336 0.094 DBMET00310 0.488 0.036 DBMET02586 0.51 0.03 DBMET02587 | DBMET02587 | |
| 0.245 | 0.023 | 0.255 | Nav1.2 sodium channel blocker | 0.255 0.021 DBMET00268 0.216 0.029 DBMET00310 0.144 0.061 DBMET02587 | DBMET00268 | |
| 0.233 | 0.012 | 0.233 | Nav1.6 sodium channel blocker | 0.2 0.019 DBMET00268 0.211 0.016 DBMET00310 0.145 0.06 DBMET02587 | ||
| 0.234 | 0.014 | 0.256 | Nav1.1 sodium channel blocker | 0.256 0.011 DBMET00268 0.234 0.014 DBMET00310 0.225 0.015 DBMET02587 | DBMET00268 | |
| 0.298 | 0.079 | 0.565 | Immunostimulant | 0.263 0.091 DBMET00268 0.342 0.067 DBMET00310 0.565 0.021 DBMET02586 0.279 0.085 DBMET02587 | DBMET02586 | |
| 0.283 | 0.066 | 0.318 | Transcription factor STAT inhibitor | 0.302 0.054 DBMET00268 0.318 0.046 DBMET00310 0.312 0.049 DBMET02587 | DBMET00310 | |
| 0.238 | 0.022 | 0.274 | 5 Hydroxytryptamine 3E antagonist | 0.274 0.009 DBMET00268 0.202 0.059 DBMET00310 0.206 0.054 DBMET02587 | DBMET00268 | |
| 0.224 | 0.011 | 0.379 | Catalase inhibitor | 0.215 0.013 DBMET00268 0.182 0.019 DBMET00310 0.379 0.004 DBMET02587 | DBMET02587 | |
| 0.224 | 0.022 | 0.324 | ATPase inhibitor | 0.176 0.063 DBMET00268 0.24 0.016 DBMET00310 0.324 0.005 DBMET02586 0.231 0.019 DBMET02587 | DBMET02586 | |
| 0.234 | 0.034 | 0.234 | Diuretic | 0.157 0.072 DBMET00268 0.221 0.037 DBMET00310 0.226 0.036 DBMET02586 0.177 0.056 DBMET02587 | ||
| 0.211 | 0.019 | 0.227 | Toll-Like receptor 2 antagonist | 0.222 0.015 DBMET00268 0.225 0.014 DBMET00310 0.112 0.087 DBMET02586 0.227 0.014 DBMET02587 | DBMET02587 | |
| 0.196 | 0.005 | 0.216 | Glutamate release inhibitor | 0.198 0.005 DBMET00268 0.16 0.008 DBMET00310 0.216 0.004 DBMET02586 0.202 0.005 DBMET02587 | DBMET02586 | |
| 0.254 | 0.064 | 0.312 | Tyrosine 3 hydroxylase inhibitor | 0.283 0.043 DBMET00268 0.277 0.046 DBMET00310 0.312 0.028 DBMET02587 | DBMET02587 | |
| 0.184 | 0.002 | 0.188 | Beta 1 adrenoreceptor agonist | 0.047 0.004 DBMET00268 0.188 0.002 DBMET00310 0.03 0.008 DBMET02587 | DBMET00310 | |
| 0.207 | 0.027 | 0.207 | Calcium channel blocker | 0.17 0.044 DBMET00310 | ||
| 0.178 | 0.002 | 0.178 | Beta 3 adrenoreceptor agonist | 0.02 0.005 DBMET00268 0.17 0.002 DBMET00310 0.017 0.005 DBMET02587 | ||
| 0.242 | 0.072 | 0.412 | DNA synthesis inhibitor | 0.242 0.072 DBMET00268 0.279 0.051 DBMET00310 0.412 0.02 DBMET02586 0.255 0.063 DBMET02587 | DBMET02586 | |
| 0.224 | 0.055 | 0.258 | Nitric-oxide synthase stimulant | 0.245 0.036 DBMET00268 0.258 0.028 DBMET00310 0.187 0.113 DBMET02586 0.237 0.042 DBMET02587 | DBMET00310 | |
| 0.263 | 0.102 | 0.313 | Caspase 3 stimulant | 0.273 0.095 DBMET00268 0.311 0.074 DBMET00310 0.293 0.082 DBMET02586 0.313 0.072 DBMET02587 | DBMET02587 | |
| 0.175 | 0.016 | 0.176 | Sphingomyelinase inhibitor | 0.176 0.015 DBMET00268 0.155 0.022 DBMET00310 0.152 0.024 DBMET02586 0.13 0.034 DBMET02587 | DBMET00268 | |
| 0.238 | 0.082 | 0.407 | Superoxide dismutase inhibitor | 0.407 0.025 DBMET00268 0.238 0.083 DBMET00310 0.328 0.042 DBMET02587 | DBMET00268 | |
| 0.223 | 0.073 | 0.358 | Peptidyltransferase inhibitor | 0.281 0.032 DBMET00268 0.252 0.049 DBMET00310 0.358 0.011 DBMET02586 0.216 0.081 DBMET02587 | DBMET02586 | |
| 0.154 | 0.004 | 0.154 | 5 Hydroxytryptamine 1B agonist | 0.122 0.005 DBMET00268 0.116 0.005 DBMET00310 0.055 0.034 DBMET02587 | ||
| 0.161 | 0.013 | 0.187 | MAP kinase kinase 1 inhibitor | 0.187 0.006 DBMET00268 0.162 0.012 DBMET00310 0.1 0.057 DBMET02587 | DBMET00268 | |
| 0.301 | 0.157 | 0.358 | Calcium channel L-type activator | 0.358 0.111 DBMET00268 0.297 0.16 DBMET00310 0.335 0.129 DBMET02587 | DBMET00268 | |
| 0.144 | 0.003 | 0.165 | Beta 2 adrenoreceptor agonist | 0.085 0.007 DBMET00268 0.165 0.003 DBMET00310 0.067 0.027 DBMET02587 | DBMET00310 | |
| 0.145 | 0.004 | 0.145 | Sphingosine 1-phosphate receptor 3 agonist | 0.127 0.005 DBMET00268 0.128 0.005 DBMET00310 0.079 0.009 DBMET02587 | ||
| 0.137 | 0.003 | 0.137 | Calcium-sensing receptor antagonist | 0.097 0.004 DBMET00268 0.137 0.003 DBMET00310 0.049 0.005 DBMET02587 | ||
| 0.169 | 0.034 | 0.176 | Adenylate cyclase inhibitor | 0.14 0.052 DBMET00268 0.176 0.032 DBMET00310 0.111 0.074 DBMET02586 0.126 0.063 DBMET02587 | DBMET00310 | |
| 0.271 | 0.137 | 0.406 | GABA C receptor rho-3 antagonist | 0.38 0.071 DBMET00268 0.363 0.079 DBMET00310 0.406 0.059 DBMET02587 | DBMET02587 | |
| 0.216 | 0.084 | 0.446 | Hypolipemic | 0.196 0.097 DBMET00268 0.199 0.095 DBMET00310 0.283 0.054 DBMET02586 0.446 0.018 DBMET02587 | DBMET02587 | |
| 0.16 | 0.028 | 0.163 | Bronchodilator | 0.163 0.027 DBMET00310 | DBMET00310 | |
| 0.241 | 0.109 | 0.28 | Hypoxia-inducible factor 1 alpha inhibitor | 0.193 0.16 DBMET00268 0.28 0.076 DBMET00310 0.206 0.145 DBMET02586 0.239 0.11 DBMET02587 | DBMET00310 | |
| 0.157 | 0.028 | 0.253 | Mucolytic | 0.181 0.018 DBMET00268 0.168 0.023 DBMET00310 0.14 0.039 DBMET02586 0.253 0.006 DBMET02587 | DBMET02587 | |
| 0.151 | 0.023 | 0.217 | Creatine kinase inhibitor | 0.164 0.019 DBMET00268 0.217 0.008 DBMET00310 0.184 0.013 DBMET02587 | DBMET00310 | |
| 0.183 | 0.057 | 0.247 | Phospholipase C inhibitor | 0.247 0.025 DBMET00268 0.193 0.049 DBMET00310 0.153 0.099 DBMET02586 0.221 0.033 DBMET02587 | DBMET00268 | |
| 0.217 | 0.092 | 0.237 | Neuropeptide Y2 antagonist | 0.237 0.069 DBMET00268 0.199 0.121 DBMET00310 0.177 0.166 DBMET02587 | DBMET00268 | |
| 0.129 | 0.004 | 0.157 | Sphingosine 1-phosphate receptor agonist | 0.157 0.004 DBMET00268 0.087 0.007 DBMET00310 0.119 0.005 DBMET02587 | DBMET00268 | |
| 0.136 | 0.014 | 0.321 | Phenylalanine 4-hydroxylase inhibitor | 0.321 0.004 DBMET00268 0.138 0.014 DBMET00310 0.304 0.004 DBMET02587 | DBMET00268 | |
| 0.135 | 0.016 | 0.172 | Ornithine decarboxylase inhibitor | 0.172 0.007 DBMET00268 0.143 0.013 DBMET00310 0.121 0.025 DBMET02587 | DBMET00268 | |
| 0.142 | 0.025 | 0.198 | Topoisomerase II alpha inhibitor | 0.198 0.015 DBMET00268 0.186 0.017 DBMET00310 0.179 0.018 DBMET02586 0.128 0.028 DBMET02587 | DBMET00268 | |
| 0.139 | 0.024 | 0.139 | Factor V inhibitor | 0.102 0.064 DBMET00268 0.131 0.03 DBMET00310 0.107 0.056 DBMET02586 | ||
| 0.198 | 0.085 | 0.321 | Interleukin antagonist | 0.321 0.043 DBMET00268 0.212 0.078 DBMET00310 0.205 0.081 DBMET02587 | DBMET00268 | |
| 0.192 | 0.079 | 0.299 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.284 0.029 DBMET00268 0.218 0.059 DBMET00310 0.155 0.138 DBMET02586 0.299 0.024 DBMET02587 | DBMET02587 | |
| 0.207 | 0.095 | 0.397 | Antiamyloidogenic | 0.152 0.144 DBMET00268 0.256 0.068 DBMET00310 0.397 0.029 DBMET02586 | DBMET02586 | |
| 0.124 | 0.015 | 0.124 | Calcium channel L-type blocker | 0.07 0.052 DBMET00268 0.099 0.025 DBMET00310 | ||
| 0.154 | 0.045 | 0.27 | Alkylator | 0.208 0.024 DBMET00268 0.188 0.03 DBMET00310 0.27 0.014 DBMET02586 0.134 0.056 DBMET02587 | DBMET02586 | |
| 0.126 | 0.021 | 0.126 | Somatostatin 1 agonist | 0.097 0.036 DBMET00268 0.124 0.022 DBMET00310 0.077 0.055 DBMET02586 | ||
| 0.125 | 0.02 | 0.202 | Keratolytic | 0.188 0.009 DBMET00268 0.195 0.009 DBMET00310 0.202 0.008 DBMET02587 | DBMET02587 | |
| 0.307 | 0.203 | 0.375 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.375 0.124 DBMET00268 0.365 0.134 DBMET02587 | DBMET00268 | |
| 0.141 | 0.039 | 0.278 | Expectorant | 0.174 0.027 DBMET00268 0.157 0.033 DBMET00310 0.275 0.01 DBMET02586 0.278 0.01 DBMET02587 | DBMET02587 | |
| 0.136 | 0.037 | 0.138 | Nav1.5 sodium channel blocker | 0.138 0.035 DBMET00268 0.112 0.065 DBMET00310 | DBMET00268 | |
| 0.141 | 0.042 | 0.168 | Aminopeptidase B inhibitor | 0.168 0.03 DBMET00268 0.135 0.044 DBMET00310 0.165 0.032 DBMET02587 | DBMET00268 | |
| 0.128 | 0.029 | 0.16 | Alcohol dehydrogenase inhibitor | 0.16 0.018 DBMET00268 0.143 0.023 DBMET00310 0.089 0.065 DBMET02586 0.158 0.018 DBMET02587 | DBMET00268 | |
| 0.138 | 0.041 | 0.138 | Alpha adrenoreceptor antagonist | 0.11 0.051 DBMET00310 | ||
| 0.146 | 0.05 | 0.423 | Aldehyde dehydrogenase inhibitor | 0.286 0.013 DBMET00268 0.155 0.045 DBMET00310 0.108 0.085 DBMET02586 0.423 0.005 DBMET02587 | DBMET02587 | |
| 0.1 | 0.005 | 0.15 | Calcium channel P-type blocker | 0.15 0.003 DBMET00268 0.079 0.015 DBMET00310 0.115 0.004 DBMET02587 | DBMET00268 | |
| 0.116 | 0.021 | 0.128 | Aminopeptidase I inhibitor | 0.115 0.021 DBMET00268 0.108 0.024 DBMET00310 0.128 0.017 DBMET02587 | DBMET02587 | |
| 0.171 | 0.078 | 0.341 | Succinate dehydrogenase inhibitor | 0.237 0.027 DBMET00268 0.166 0.087 DBMET00310 0.341 0.006 DBMET02587 | DBMET02587 | |
| 0.113 | 0.021 | 0.122 | Granulocyte macrophage colony stimulating factor agonist | 0.103 0.031 DBMET00268 0.107 0.026 DBMET00310 0.122 0.015 DBMET02587 | DBMET02587 | |
| 0.096 | 0.005 | 0.12 | Sphingosine 1-phosphate receptor 1 agonist | 0.12 0.004 DBMET00268 0.071 0.008 DBMET00310 0.082 0.005 DBMET02587 | DBMET00268 | |
| 0.106 | 0.015 | 0.106 | Secretase beta inhibitor | 0.071 0.047 DBMET00268 0.086 0.03 DBMET00310 | ||
| 0.184 | 0.093 | 0.242 | MAP kinase kinase 2 inhibitor | 0.242 0.058 DBMET00268 0.19 0.089 DBMET00310 | DBMET00268 | |
| 0.106 | 0.017 | 0.106 | Cathepsin D inhibitor | 0.087 0.023 DBMET00310 | ||
| 0.152 | 0.063 | 0.152 | Neuropeptide Y1 antagonist | 0.145 0.073 DBMET00310 | ||
| 0.155 | 0.069 | 0.294 | Phospholipase A2 inhibitor | 0.216 0.035 DBMET00268 0.156 0.069 DBMET00310 0.157 0.068 DBMET02586 0.294 0.014 DBMET02587 | DBMET02587 | |
| 0.128 | 0.042 | 0.128 | Protease inhibitor | 0.091 0.073 DBMET00268 0.121 0.046 DBMET00310 0.088 0.076 DBMET02587 | ||
| 0.124 | 0.041 | 0.26 | UDP-glucose 4-epimerase inhibitor | 0.17 0.023 DBMET00268 0.133 0.036 DBMET00310 0.251 0.013 DBMET02586 0.26 0.013 DBMET02587 | DBMET02587 | |
| 0.123 | 0.04 | 0.185 | Toll-Like receptor 4 antagonist | 0.152 0.02 DBMET00268 0.133 0.032 DBMET00310 0.185 0.009 DBMET02586 0.149 0.022 DBMET02587 | DBMET02586 | |
| 0.158 | 0.079 | 0.158 | Cyclin-dependent kinase 3 inhibitor | 0.152 0.091 DBMET00268 0.15 0.096 DBMET00310 | ||
| 0.147 | 0.068 | 0.158 | MAP kinase kinase 4 inhibitor | 0.158 0.049 DBMET00268 0.154 0.054 DBMET00310 | DBMET00268 | |
| 0.084 | 0.014 | 0.084 | Sphingosine kinase inhibitor | 0.084 0.014 DBMET00268 0.084 0.013 DBMET00310 | ||
| 0.139 | 0.069 | 0.372 | Amylase inhibitor | 0.234 0.033 DBMET00268 0.214 0.04 DBMET00310 0.372 0.011 DBMET02586 0.319 0.016 DBMET02587 | DBMET02586 | |
| 0.156 | 0.087 | 0.169 | Neurotensin receptor agonist | 0.164 0.072 DBMET00268 0.169 0.064 DBMET00310 0.164 0.073 DBMET02587 | DBMET00310 | |
| 0.107 | 0.037 | 0.207 | NADH dehydrogenase inhibitor | 0.138 0.021 DBMET00268 0.113 0.033 DBMET00310 0.207 0.01 DBMET02586 0.181 0.012 DBMET02587 | DBMET02586 | |
| 0.102 | 0.033 | 0.102 | Histamine H2 receptor antagonist | 0.092 0.045 DBMET00268 0.084 0.058 DBMET00310 | ||
| 0.118 | 0.049 | 0.194 | Mediator release inhibitor | 0.118 0.049 DBMET00268 0.137 0.035 DBMET00310 0.194 0.015 DBMET02586 0.153 0.027 DBMET02587 | DBMET02586 | |
| 0.127 | 0.06 | 0.193 | Sphingosine 1-phosphate receptor 4 antagonist | 0.152 0.031 DBMET00268 0.193 0.01 DBMET02587 | DBMET02587 | |
| 0.149 | 0.083 | 0.217 | Melanin inhibitor | 0.181 0.051 DBMET00268 0.172 0.057 DBMET00310 0.178 0.053 DBMET02586 0.217 0.035 DBMET02587 | DBMET02587 | |
| 0.073 | 0.007 | 0.073 | Plasmepsin II inhibitor | 0.051 0.017 DBMET00268 0.054 0.015 DBMET00310 | ||
| 0.08 | 0.015 | 0.095 | Sphingosine kinase 2 inhibitor | 0.095 0.009 DBMET00268 0.072 0.02 DBMET00310 | DBMET00268 | |
| 0.088 | 0.024 | 0.088 | Phospholipase D inhibitor | 0.079 0.036 DBMET00310 0.065 0.064 DBMET02587 | ||
| 0.111 | 0.048 | 0.253 | GABA C receptor rho-1 antagonist | 0.253 0.004 DBMET00268 0.125 0.036 DBMET00310 0.161 0.017 DBMET02587 | DBMET00268 | |
| 0.121 | 0.058 | 0.134 | Caspase 3 inhibitor | 0.123 0.055 DBMET00310 0.134 0.041 DBMET02587 | DBMET02587 | |
| 0.074 | 0.015 | 0.078 | Epithelial sodium channel blocker | 0.078 0.013 DBMET00268 0.064 0.024 DBMET00310 0.052 0.044 DBMET02587 | DBMET00268 | |
| 0.218 | 0.16 | 0.441 | Interleukin 2 agonist | 0.294 0.078 DBMET00268 0.235 0.136 DBMET00310 0.441 0.017 DBMET02586 0.27 0.098 DBMET02587 | DBMET02586 | |
| 0.126 | 0.068 | 0.179 | MAP kinase kinase inhibitor | 0.179 0.037 DBMET00268 0.131 0.064 DBMET00310 | DBMET00268 | |
| 0.111 | 0.052 | 0.232 | Adenylate kinase inhibitor | 0.178 0.019 DBMET00268 0.105 0.06 DBMET00310 0.232 0.011 DBMET02587 | DBMET02587 | |
| 0.079 | 0.021 | 0.123 | Heat shock protein 90 beta antagonist | 0.069 0.029 DBMET00268 0.123 0.006 DBMET00310 | DBMET00310 | |
| 0.071 | 0.014 | 0.099 | Lysophosphatidic acid 3 receptor antagonist | 0.069 0.015 DBMET00268 0.061 0.022 DBMET00310 0.099 0.005 DBMET02587 | DBMET02587 | |
| 0.087 | 0.03 | 0.087 | Phosphodiesterase III inhibitor | 0.073 0.041 DBMET00310 | ||
| 0.102 | 0.046 | 0.416 | Triose-phosphate isomerase inhibitor | 0.183 0.013 DBMET00268 0.092 0.057 DBMET00310 0.15 0.02 DBMET02586 0.416 0.003 DBMET02587 | DBMET02587 | |
| 0.116 | 0.061 | 0.116 | Calcium channel (voltage-sensitive) blocker | |||
| 0.098 | 0.043 | 0.128 | ATPase (Vacuolar H+) inhibitor | 0.11 0.028 DBMET00268 0.107 0.031 DBMET00310 0.106 0.033 DBMET02586 0.128 0.015 DBMET02587 | DBMET02587 | |
| 0.058 | 0.005 | 0.058 | Plasmepsin I inhibitor | 0.031 0.02 DBMET00268 0.051 0.007 DBMET00310 0.027 0.025 DBMET02587 | ||
| 0.137 | 0.084 | 0.173 | Ca2+-transporting ATPase inhibitor | 0.151 0.041 DBMET00268 0.141 0.071 DBMET00310 0.137 0.087 DBMET02586 0.173 0.011 DBMET02587 | DBMET02587 | |
| 0.071 | 0.018 | 0.071 | Myc inhibitor | 0.067 0.022 DBMET00310 | ||
| 0.103 | 0.051 | 0.315 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.13 0.034 DBMET00268 0.083 0.076 DBMET00310 0.113 0.043 DBMET02586 0.315 0.005 DBMET02587 | DBMET02587 | |
| 0.203 | 0.152 | 0.259 | Insulysin inhibitor | 0.259 0.088 DBMET00268 0.186 0.18 DBMET00310 0.257 0.09 DBMET02587 | DBMET00268 | |
| 0.14 | 0.09 | 0.275 | Thrombolytic | 0.202 0.051 DBMET00268 0.147 0.084 DBMET00310 0.275 0.028 DBMET02586 0.233 0.038 DBMET02587 | DBMET02586 | |
| 0.125 | 0.075 | 0.144 | Vanilloid 1 agonist | 0.138 0.053 DBMET00268 0.144 0.045 DBMET00310 0.116 0.099 DBMET02586 0.142 0.047 DBMET02587 | DBMET00310 | |
| 0.143 | 0.093 | 0.206 | Growth hormone agonist | 0.206 0.056 DBMET00268 0.14 0.095 DBMET00310 0.152 0.086 DBMET02587 | DBMET00268 | |
| 0.087 | 0.037 | 0.087 | 5 Hydroxytryptamine 1A antagonist | 0.059 0.054 DBMET00268 0.076 0.043 DBMET00310 | ||
| 0.098 | 0.05 | 0.098 | Alpha 2 adrenoreceptor antagonist | 0.094 0.052 DBMET00310 | ||
| 0.055 | 0.012 | 0.055 | Sphingosine kinase 1 inhibitor | 0.052 0.014 DBMET00268 0.054 0.013 DBMET00310 | ||
| 0.222 | 0.182 | 0.356 | Calcium channel activator | 0.34 0.056 DBMET00268 0.356 0.046 DBMET02587 | DBMET02587 | |
| 0.209 | 0.168 | 0.477 | Apoptosis antagonist | 0.249 0.128 DBMET00310 0.477 0.023 DBMET02586 0.269 0.11 DBMET02587 | DBMET02586 | |
| 0.078 | 0.038 | 0.343 | Selectin antagonist | 0.081 0.036 DBMET00268 0.077 0.038 DBMET00310 0.343 0.004 DBMET02586 0.137 0.02 DBMET02587 | DBMET02586 | |
| 0.103 | 0.062 | 0.103 | Gastric antisecretory | 0.098 0.068 DBMET00268 0.096 0.071 DBMET00310 0.095 0.072 DBMET02587 | ||
| 0.122 | 0.082 | 0.158 | Sodium channel blocker | 0.158 0.053 DBMET00268 | DBMET00268 | |
| 0.118 | 0.078 | 0.128 | Cathepsin H inhibitor | 0.128 0.066 DBMET00268 0.122 0.073 DBMET02587 | DBMET00268 | |
| 0.132 | 0.092 | 0.434 | Hemostatic | 0.139 0.083 DBMET00268 0.133 0.091 DBMET00310 0.434 0.006 DBMET02586 0.151 0.067 DBMET02587 | DBMET02586 | |
| 0.087 | 0.047 | 0.103 | Estrogen-related receptor beta agonist | 0.093 0.034 DBMET00268 0.095 0.032 DBMET00310 0.103 0.021 DBMET02587 | DBMET02587 | |
| 0.082 | 0.042 | 0.23 | Glutamate decarboxylase inhibitor | 0.174 0.009 DBMET00268 0.091 0.035 DBMET00310 0.23 0.005 DBMET02587 | DBMET02587 | |
| 0.132 | 0.093 | 0.135 | Acetylcholine M1 receptor antagonist | 0.119 0.11 DBMET00268 0.135 0.09 DBMET00310 | DBMET00310 | |
| 0.073 | 0.034 | 0.082 | 5 Hydroxytryptamine 2A agonist | 0.082 0.026 DBMET00268 0.076 0.031 DBMET00310 | DBMET00268 | |
| 0.112 | 0.074 | 0.223 | Topoisomerase II inhibitor | 0.149 0.05 DBMET00268 0.152 0.048 DBMET00310 0.223 0.029 DBMET02586 0.132 0.059 DBMET02587 | DBMET02586 | |
| 0.096 | 0.06 | 0.134 | Phosphodiesterase 6D inhibitor | 0.121 0.024 DBMET00268 0.103 0.046 DBMET00310 0.112 0.034 DBMET02586 0.134 0.016 DBMET02587 | DBMET02587 | |
| 0.106 | 0.07 | 0.279 | GABA C receptor antagonist | 0.279 0.005 DBMET00268 0.127 0.046 DBMET00310 0.154 0.028 DBMET02587 | DBMET00268 | |
| 0.079 | 0.043 | 0.084 | Vanilloid 4 agonist | 0.084 0.035 DBMET00310 | DBMET00310 | |
| 0.061 | 0.025 | 0.081 | Alpha-mannosidase inhibitor | 0.076 0.013 DBMET00268 0.061 0.025 DBMET00310 0.077 0.013 DBMET02586 0.081 0.011 DBMET02587 | DBMET02587 | |
| 0.054 | 0.019 | 0.054 | Geranyltranstransferase inhibitor | 0.05 0.023 DBMET00268 0.043 0.032 DBMET00310 | ||
| 0.11 | 0.075 | 0.115 | Proteasome inhibitor | 0.115 0.07 DBMET00310 | DBMET00310 | |
| 0.097 | 0.062 | 0.113 | Interleukin 1 beta converting enzyme inhibitor | 0.113 0.041 DBMET02587 | DBMET02587 | |
| 0.044 | 0.01 | 0.057 | Cholesterol ester transfer protein antagonist | 0.057 0.005 DBMET00268 0.035 0.018 DBMET00310 0.053 0.006 DBMET02587 | DBMET00268 | |
| 0.066 | 0.033 | 0.066 | Cathepsin E inhibitor | 0.061 0.039 DBMET00310 | ||
| 0.175 | 0.143 | 0.229 | RNA-directed DNA polymerase inhibitor | 0.214 0.08 DBMET00268 0.203 0.095 DBMET00310 0.229 0.065 DBMET02587 | DBMET02587 | |
| 0.068 | 0.036 | 0.204 | Carbamoyl phosphate synthetase inhibitor | 0.117 0.016 DBMET00268 0.062 0.041 DBMET00310 0.204 0.007 DBMET02587 | DBMET02587 | |
| 0.078 | 0.048 | 0.078 | 5 Hydroxytryptamine 1 antagonist | 0.062 0.061 DBMET00310 | ||
| 0.077 | 0.048 | 0.195 | Glutamate dehydrogenase inhibitor | 0.135 0.019 DBMET00268 0.087 0.039 DBMET00310 0.195 0.01 DBMET02587 | DBMET02587 | |
| 0.099 | 0.071 | 0.299 | AMP-activated protein kinase stimulant | 0.134 0.038 DBMET00268 0.117 0.051 DBMET00310 0.299 0.005 DBMET02586 0.166 0.019 DBMET02587 | DBMET02586 | |
| 0.036 | 0.007 | 0.036 | Lysophosphatidic acid receptor 1 agonist | 0.029 0.012 DBMET00268 0.026 0.015 DBMET00310 0.035 0.007 DBMET02587 | ||
| 0.04 | 0.012 | 0.041 | Lysophosphatidic acid 2 receptor antagonist | 0.037 0.014 DBMET00310 0.041 0.012 DBMET02587 | DBMET02587 | |
| 0.097 | 0.07 | 0.097 | Folate antagonist | 0.092 0.083 DBMET02586 | ||
| 0.051 | 0.024 | 0.08 | Mannosidase inhibitor | 0.08 0.009 DBMET00268 0.051 0.025 DBMET00310 0.074 0.01 DBMET02586 0.077 0.009 DBMET02587 | DBMET00268 | |
| 0.057 | 0.032 | 0.06 | Immunoglobulin Fc receptor antagonist | 0.06 0.025 DBMET00268 0.054 0.043 DBMET02587 | DBMET00268 | |
| 0.106 | 0.081 | 0.145 | Microtubule formation inhibitor | 0.119 0.061 DBMET00268 0.107 0.079 DBMET00310 0.136 0.046 DBMET02586 0.145 0.04 DBMET02587 | DBMET02587 | |
| 0.084 | 0.06 | 0.197 | NMDA receptor antagonist | 0.197 0.015 DBMET00268 0.108 0.042 DBMET00310 0.081 0.065 DBMET02587 | DBMET00268 | |
| 0.049 | 0.026 | 0.06 | Neuraminidase (Influenza A) inhibitor | 0.046 0.031 DBMET00268 0.049 0.025 DBMET00310 0.06 0.013 DBMET02586 | DBMET02586 | |
| 0.058 | 0.037 | 0.44 | Alcohol oxidase inhibitor | 0.373 0.004 DBMET00268 0.07 0.029 DBMET00310 0.44 0.004 DBMET02587 | DBMET02587 | |
| 0.11 | 0.089 | 0.211 | Cyclooxygenase 3 inhibitor | 0.155 0.044 DBMET00268 0.132 0.065 DBMET00310 0.211 0.015 DBMET02586 0.185 0.025 DBMET02587 | DBMET02586 | |
| 0.046 | 0.025 | 0.047 | HIV-1 protease inhibitor | 0.047 0.024 DBMET00310 | DBMET00310 | |
| 0.167 | 0.146 | 0.494 | Antioxidant | 0.169 0.143 DBMET00268 0.264 0.077 DBMET00310 0.494 0.021 DBMET02586 0.37 0.041 DBMET02587 | DBMET02586 | |
| 0.055 | 0.035 | 0.081 | Ornithine carbamoyltransferase inhibitor | 0.081 0.021 DBMET00268 0.049 0.041 DBMET00310 0.073 0.024 DBMET02587 | DBMET00268 | |
| 0.039 | 0.019 | 0.051 | Squalene synthetase inhibitor | 0.03 0.023 DBMET00310 0.051 0.014 DBMET02586 0.033 0.022 DBMET02587 | DBMET02586 | |
| 0.062 | 0.043 | 0.129 | Prostaglandin F2 alpha antagonist | 0.084 0.02 DBMET00268 0.056 0.054 DBMET00310 0.129 0.005 DBMET02587 | DBMET02587 | |
| 0.024 | 0.005 | 0.044 | Antibiotic Anthracycline-like | 0.025 0.005 DBMET00268 0.03 0.004 DBMET00310 0.044 0.002 DBMET02586 0.025 0.005 DBMET02587 | DBMET02586 | |
| 0.064 | 0.045 | 0.12 | Neuraminidase (influenza) inhibitor | 0.062 0.05 DBMET00268 0.072 0.032 DBMET00310 0.12 0.012 DBMET02586 | DBMET02586 | |
| 0.067 | 0.048 | 0.138 | Sphingosine 1-phosphate receptor 4 agonist | 0.112 0.02 DBMET00268 0.138 0.011 DBMET02587 | DBMET02587 | |
| 0.053 | 0.034 | 0.253 | Aconitate hydratase inhibitor | 0.1 0.008 DBMET00268 0.253 0.003 DBMET02587 | DBMET02587 | |
| 0.074 | 0.056 | 0.074 | Alpha 1 adrenoreceptor antagonist | |||
| 0.092 | 0.074 | 0.12 | Anabolic | 0.094 0.071 DBMET00268 0.107 0.053 DBMET00310 0.12 0.039 DBMET02587 | DBMET02587 | |
| 0.125 | 0.107 | 0.125 | Thiol protease inhibitor | |||
| 0.069 | 0.052 | 0.21 | Histidine decarboxylase inhibitor | 0.193 0.014 DBMET00268 0.111 0.028 DBMET00310 0.21 0.012 DBMET02587 | DBMET02587 | |
| 0.129 | 0.112 | 0.199 | Interferon gamma antagonist | 0.144 0.087 DBMET00268 0.146 0.084 DBMET00310 0.198 0.041 DBMET02586 0.199 0.041 DBMET02587 | DBMET02587 | |
| 0.051 | 0.034 | 0.227 | CD45 antagonist | 0.067 0.017 DBMET00268 0.047 0.043 DBMET00310 0.227 0.004 DBMET02587 | DBMET02587 | |
| 0.062 | 0.045 | 0.071 | Nitric oxide donor | 0.057 0.055 DBMET00268 0.062 0.045 DBMET00310 0.071 0.032 DBMET02586 0.069 0.034 DBMET02587 | DBMET02586 | |
| 0.058 | 0.042 | 0.061 | Carbonic anhydrase stimulant | 0.061 0.039 DBMET00268 | DBMET00268 | |
| 0.045 | 0.03 | 0.045 | Dihydroorotase inhibitor | |||
| 0.055 | 0.041 | 0.129 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.096 0.015 DBMET00268 0.052 0.045 DBMET00310 0.129 0.01 DBMET02587 | DBMET02587 | |
| 0.057 | 0.043 | 0.057 | Alpha 1d adrenoreceptor antagonist | |||
| 0.029 | 0.015 | 0.029 | Myristoyl transferase inhibitor | 0.026 0.022 DBMET00268 | ||
| 0.057 | 0.043 | 0.063 | Sphingosine 1-phosphate receptor 3 antagonist | 0.063 0.033 DBMET02587 | DBMET02587 | |
| 0.1 | 0.087 | 0.286 | Cholesterol synthesis inhibitor | 0.122 0.064 DBMET00268 0.113 0.072 DBMET00310 0.286 0.013 DBMET02587 | DBMET02587 | |
| 0.053 | 0.04 | 0.053 | Human rhinovirus A protease inhibitor | 0.052 0.041 DBMET00310 | ||
| 0.052 | 0.04 | 0.121 | Acyl-CoA dehydrogenase inhibitor | 0.101 0.016 DBMET00268 0.047 0.046 DBMET00310 0.121 0.012 DBMET02587 | DBMET02587 | |
| 0.103 | 0.093 | 0.108 | Sphingosine 1-phosphate receptor 2 agonist | 0.108 0.08 DBMET00268 0.102 0.096 DBMET02587 | DBMET00268 | |
| 0.066 | 0.056 | 0.066 | Alpha 1b adrenoreceptor antagonist | |||
| 0.113 | 0.103 | 0.113 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.112 | 0.103 | 0.218 | Lipid peroxidase inhibitor | 0.174 0.053 DBMET00310 0.218 0.035 DBMET02586 0.117 0.096 DBMET02587 | DBMET02586 | |
| 0.057 | 0.048 | 0.057 | Adrenaline uptake inhibitor | |||
| 0.051 | 0.042 | 0.123 | Leukotriene B4 antagonist | 0.065 0.023 DBMET00268 0.056 0.033 DBMET00310 0.05 0.044 DBMET02586 0.123 0.007 DBMET02587 | DBMET02587 | |
| 0.094 | 0.086 | 0.145 | Chelator | 0.145 0.037 DBMET00310 0.093 0.087 DBMET02586 | DBMET00310 | |
| 0.039 | 0.031 | 0.043 | VCAM-1 antagonist | 0.038 0.035 DBMET00268 0.037 0.036 DBMET00310 0.043 0.018 DBMET02587 | DBMET02587 | |
| 0.056 | 0.048 | 0.096 | Neuraminidase inhibitor | 0.056 0.048 DBMET00268 0.067 0.036 DBMET00310 0.096 0.017 DBMET02586 | DBMET02586 | |
| 0.038 | 0.031 | 0.043 | VCAM antagonist | 0.037 0.035 DBMET00268 0.037 0.036 DBMET00310 0.043 0.018 DBMET02587 | DBMET02587 | |
| 0.087 | 0.08 | 0.137 | Electrolyte absorption antagonist | 0.103 0.054 DBMET00268 0.137 0.025 DBMET02587 | DBMET02587 | |
| 0.021 | 0.014 | 0.021 | Neuraminidase (Influenza B) inhibitor | 0.021 0.015 DBMET00310 | ||
| 0.101 | 0.094 | 0.101 | Calcium channel N-type blocker | |||
| 0.046 | 0.04 | 0.049 | Bombesin 2 receptor antagonist | 0.049 0.034 DBMET00310 | DBMET00310 | |
| 0.086 | 0.081 | 0.12 | Carbonic anhydrase III inhibitor | 0.12 0.044 DBMET00268 0.12 0.044 DBMET00310 0.117 0.047 DBMET02587 | DBMET00310 | |
| 0.108 | 0.102 | 0.13 | Antibacterial (Helicobacter pylori) | 0.13 0.067 DBMET00268 0.119 0.083 DBMET00310 0.12 0.082 DBMET02587 | DBMET00268 | |
| 0.027 | 0.021 | 0.034 | Hedgehog signaling activator | 0.034 0.008 DBMET00268 0.032 0.009 DBMET02587 | DBMET00268 | |
| 0.069 | 0.066 | 0.069 | Potassium channel (Tandem pore domain) blocker | |||
| 0.013 | 0.01 | 0.018 | Lysophosphatidic acid receptor 3 agonist | 0.014 0.009 DBMET00268 0.018 0.006 DBMET02587 | DBMET02587 | |
| 0.016 | 0.014 | 0.018 | Vitamin D receptor agonist | 0.016 0.013 DBMET00268 0.018 0.009 DBMET02587 | DBMET02587 | |
| 0.018 | 0.018 | 0.021 | Caspase 8 inhibitor | 0.021 0.011 DBMET02587 | DBMET02587 | |
| 0.07 | 0.07 | 0.102 | Interferon agonist | 0.102 0.027 DBMET00268 0.08 0.052 DBMET02586 0.091 0.038 DBMET02587 | DBMET00268 | |
| 0.043 | 0.043 | 0.136 | Glucose-6-phosphate isomerase inhibitor | 0.063 0.016 DBMET00268 0.052 0.027 DBMET02586 0.136 0.003 DBMET02587 | DBMET02587 | |
| 0.058 | 0.059 | 0.301 | Phosphofructokinase-1 inhibitor | 0.133 0.022 DBMET00268 0.063 0.054 DBMET00310 0.111 0.028 DBMET02586 0.301 0.005 DBMET02587 | DBMET02587 | |
| 0.091 | 0.091 | 0.115 | Nav1.4 sodium channel blocker | 0.115 0.057 DBMET00268 0.093 0.088 DBMET00310 | DBMET00268 | |
| 0.147 | 0.148 | 0.323 | Platelet antagonist | 0.237 0.078 DBMET00268 0.275 0.062 DBMET02586 0.323 0.045 DBMET02587 | DBMET02587 | |
| 0.122 | 0.123 | 0.166 | GABA C receptor rho-2 antagonist | 0.15 0.074 DBMET00268 0.144 0.082 DBMET00310 0.166 0.054 DBMET02587 | DBMET02587 | |
| 0.069 | 0.071 | 0.159 | GABA B receptor agonist | 0.159 0.004 DBMET00268 0.113 0.01 DBMET02587 | DBMET00268 | |
| 0.031 | 0.032 | 0.053 | HMG CoA reductase inhibitor | 0.035 0.023 DBMET00268 0.053 0.006 DBMET02587 | DBMET02587 | |
| 0.087 | 0.089 | 0.139 | Carbonic anhydrase XV inhibitor | 0.139 0.035 DBMET00268 0.096 0.073 DBMET00310 0.089 0.085 DBMET02587 | DBMET00268 | |
| 0.094 | 0.097 | 0.098 | Electron transport complex I inhibitor | 0.097 0.089 DBMET00310 0.098 0.087 DBMET02587 | DBMET02587 | |
| 0.005 | 0.011 | 0.01 | Mannitol 2-dehydrogenase inhibitor | 0.008 0.006 DBMET00268 0.01 0.004 DBMET02587 | DBMET02587 | |
| 0.013 | 0.019 | 0.017 | Ileal bile acid transport inhibitor | 0.017 0.012 DBMET02586 | DBMET02586 | |
| 0.071 | 0.079 | 0.121 | Glutathione S-transferase inhibitor | 0.078 0.064 DBMET00310 0.121 0.022 DBMET02587 | DBMET02587 | |
| 0.101 | 0.11 | 0.157 | Sodium channel (voltage-gated) blocker | 0.157 0.05 DBMET00268 | DBMET00268 | |
| 0.076 | 0.085 | 0.092 | T cell inhibitor | 0.092 0.033 DBMET02587 | DBMET02587 | |
| 0.119 | 0.128 | 0.218 | Arachidonic acid antagonist | 0.165 0.071 DBMET00268 0.218 0.018 DBMET02587 | DBMET02587 | |
| 0.018 | 0.028 | 0.06 | Prostaglandin F2 alpha agonist | 0.028 0.01 DBMET00268 0.06 0.004 DBMET02587 | DBMET02587 | |
| 0.085 | 0.097 | 0.286 | Cystathionine beta-synthase inhibitor | 0.157 0.037 DBMET00268 0.125 0.054 DBMET00310 0.286 0.011 DBMET02587 | DBMET02587 | |
| 0.084 | 0.095 | 0.127 | DNA intercalator | 0.096 0.078 DBMET00310 0.127 0.054 DBMET02586 | DBMET02586 | |
| 0.043 | 0.054 | 0.055 | Cytokine production stimulant | 0.048 0.035 DBMET00268 0.055 0.019 DBMET02586 | DBMET02586 | |
| 0.098 | 0.11 | 0.153 | Bone formation stimulant | 0.12 0.086 DBMET00268 0.153 0.057 DBMET02587 | DBMET02587 | |
| 0.063 | 0.075 | 0.125 | Peroxisome proliferator-activated receptor gamma antagonist | 0.125 0.009 DBMET02587 | DBMET02587 | |
| 0.031 | 0.044 | 0.072 | GABA uptake inhibitor | 0.065 0.008 DBMET00268 0.072 0.006 DBMET02587 | DBMET02587 | |
| 0.018 | 0.032 | 0.025 | Isoleucine-tRNA ligase inhibitor | 0.025 0.01 DBMET00268 0.025 0.01 DBMET02587 | DBMET02587 | |
| 0.053 | 0.067 | 0.059 | Caspase 9 inhibitor | 0.059 0.049 DBMET02587 | DBMET02587 | |
| 0.103 | 0.119 | 0.177 | DNA repair enzyme inhibitor | 0.129 0.057 DBMET00268 0.177 0.014 DBMET02586 0.137 0.045 DBMET02587 | DBMET02586 | |
| 0.023 | 0.039 | 0.051 | Arginase inhibitor | 0.051 0.015 DBMET02586 0.033 0.028 DBMET02587 | DBMET02586 | |
| 0.015 | 0.032 | 0.019 | Methylmalonyl-CoA mutase inhibitor | 0.019 0.01 DBMET02587 | DBMET02587 | |
| 0.029 | 0.047 | 0.034 | Calcium-independent phospholipase A2 inhibitor | 0.034 0.025 DBMET02587 | DBMET02587 | |
| 0.016 | 0.033 | 0.022 | Methionyl aminopeptidase 2 inhibitor | 0.022 0.021 DBMET00268 | DBMET00268 | |
| 0.047 | 0.065 | 0.062 | Sphingosine 1-phosphate receptor 1 antagonist | 0.062 0.027 DBMET02587 | DBMET02587 | |
| 0.046 | 0.064 | 0.07 | Sphingosine 1-phosphate receptor 5 agonist | 0.052 0.042 DBMET00268 0.07 0.016 DBMET02587 | DBMET02587 | |
| 0.021 | 0.04 | 0.137 | Prostaglandin agonist | 0.033 0.018 DBMET00268 0.137 0.004 DBMET02587 | DBMET02587 | |
| 0.041 | 0.06 | 0.059 | Squalene epoxidase inhibitor | 0.059 0.022 DBMET00268 0.052 0.03 DBMET02587 | DBMET00268 | |
| 0.024 | 0.044 | 0.075 | Phosphoglycerate kinase inhibitor | 0.075 0.009 DBMET00268 0.05 0.014 DBMET02587 | DBMET00268 | |
| 0.021 | 0.041 | 0.05 | Prostaglandin D2 agonist | 0.05 0.008 DBMET02587 | DBMET02587 | |
| 0.057 | 0.08 | 0.097 | Glutamate (mGluR6) antagonist | 0.076 0.029 DBMET00268 0.097 0.012 DBMET02587 | DBMET02587 | |
| 0.034 | 0.059 | 0.078 | Glutamate (mGluR4) antagonist | 0.059 0.014 DBMET00268 0.078 0.009 DBMET02587 | DBMET02587 | |
| 0.052 | 0.077 | 0.073 | Interferon inducer | 0.073 0.031 DBMET00268 0.059 0.057 DBMET02586 0.065 0.043 DBMET02587 | DBMET00268 | |
| 0.016 | 0.041 | 0.074 | Prostaglandin EP4 antagonist | 0.074 0.005 DBMET02587 | DBMET02587 | |
| 0.099 | 0.124 | 0.244 | Protein kinase stimulant | 0.175 0.052 DBMET00268 0.121 0.091 DBMET02586 0.244 0.028 DBMET02587 | DBMET02587 | |
| 0.009 | 0.035 | 0.03 | Integrin beta7 antagonist | 0.03 0.009 DBMET02587 | DBMET02587 | |
| 0.008 | 0.034 | 0.032 | Prostacyclin agonist | 0.032 0.005 DBMET02587 | DBMET02587 | |
| 0.054 | 0.081 | 0.082 | Cathepsin G inhibitor | 0.082 0.042 DBMET02587 | DBMET02587 | |
| 0.027 | 0.054 | 0.066 | Antibiotic Aminoglycoside-like | 0.051 0.013 DBMET00268 0.066 0.007 DBMET02586 | DBMET02586 | |
| 0.022 | 0.05 | 0.028 | Estrogen-related receptor gamma antagonist | 0.028 0.021 DBMET00268 | DBMET00268 | |
| 0.047 | 0.075 | 0.173 | Leukotriene antagonist | 0.064 0.046 DBMET00268 0.173 0.008 DBMET02587 | DBMET02587 | |
| 0.014 | 0.042 | 0.031 | Leukotriene B4 receptor 2 antagonist | 0.031 0.008 DBMET02587 | DBMET02587 | |
| 0.012 | 0.041 | 0.092 | Prostaglandin E2 agonist | 0.022 0.018 DBMET00268 0.092 0.004 DBMET02587 | DBMET02587 | |
| 0.009 | 0.039 | 0.024 | Integrin alpha4beta7 antagonist | 0.024 0.012 DBMET02587 | DBMET02587 | |
| 0.021 | 0.051 | 0.1 | Fumarate hydratase inhibitor | 0.04 0.019 DBMET00268 0.1 0.005 DBMET02587 | DBMET02587 | |
| 0.033 | 0.064 | 0.065 | GABA B receptor antagonist | 0.065 0.01 DBMET00268 | DBMET00268 | |
| 0.005 | 0.036 | 0.095 | Prostaglandin EP4 agonist | 0.095 0.004 DBMET02587 | DBMET02587 | |
| 0.081 | 0.112 | 0.128 | Interleukin 1b antagonist | 0.116 0.066 DBMET00268 0.128 0.057 DBMET02587 | DBMET02587 | |
| 0.017 | 0.049 | 0.07 | Prostacyclin antagonist | 0.07 0.007 DBMET02587 | DBMET02587 | |
| 0.015 | 0.048 | 0.026 | Lysine carboxypeptidase inhibitor | 0.026 0.02 DBMET02587 | DBMET02587 | |
| 0.029 | 0.061 | 0.069 | Thromboxane A2 antagonist | 0.069 0.022 DBMET02587 | DBMET02587 | |
| 0.087 | 0.12 | 0.152 | Photosensitizer | 0.13 0.046 DBMET00268 0.117 0.06 DBMET02586 0.152 0.03 DBMET02587 | DBMET02587 | |
| 0.037 | 0.071 | 0.152 | Prostaglandin EP2 antagonist | 0.056 0.045 DBMET00268 0.152 0.009 DBMET02587 | DBMET02587 | |
| 0.033 | 0.066 | 0.075 | Thromboxane antagonist | 0.075 0.023 DBMET02587 | DBMET02587 | |
| 0.05 | 0.084 | 0.089 | Na+ K+ transporting ATPase inhibitor | 0.089 0.042 DBMET00268 0.089 0.042 DBMET02586 0.075 0.055 DBMET02587 | DBMET02586 | |
| 0.017 | 0.053 | 0.036 | Growth hormone releasing factor agonist | 0.036 0.021 DBMET00268 | DBMET00268 | |
| 0.066 | 0.102 | 0.087 | MAP kinase kinase 7 inhibitor | 0.087 0.029 DBMET00268 0.076 0.059 DBMET00310 | DBMET00268 | |
| 0.011 | 0.047 | 0.027 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.027 0.02 DBMET00268 | DBMET00268 | |
| 0.159 | 0.196 | 0.225 | 12-Lipoxygenase inhibitor | 0.225 0.126 DBMET00310 | DBMET00310 | |
| 0.006 | 0.043 | 0.012 | Calcium-dependent phospholipase A2 inhibitor | 0.012 0.009 DBMET02587 | DBMET02587 | |
| 0.027 | 0.065 | 0.054 | Adenosine deaminase inhibitor | 0.054 0.026 DBMET00268 0.051 0.029 DBMET02587 | DBMET00268 | |
| 0.068 | 0.106 | 0.098 | Prolactin inhibitor | 0.085 0.073 DBMET00268 0.092 0.064 DBMET00310 0.098 0.057 DBMET02587 | DBMET02587 | |
| 0.111 | 0.15 | 0.562 | Angiogenesis stimulant | 0.174 0.108 DBMET00268 0.187 0.101 DBMET00310 0.562 0.009 DBMET02586 0.158 0.117 DBMET02587 | DBMET02586 | |
| 0.067 | 0.106 | 0.106 | Aminoacyl-tRNA synthetase inhibitor | 0.106 0.039 DBMET00268 0.086 0.065 DBMET00310 0.087 0.063 DBMET02587 | DBMET00268 | |
| 0.004 | 0.043 | 0.019 | Thromboxane agonist | 0.019 0.004 DBMET02587 | DBMET02587 | |
| 0.01 | 0.049 | 0.053 | Prostaglandin EP2 agonist | 0.053 0.005 DBMET02587 | DBMET02587 | |
| 0.014 | 0.054 | 0.039 | Glucagon receptor antagonist | 0.039 0.014 DBMET02587 | DBMET02587 | |
| 0.215 | 0.255 | 0.526 | Apoptosis agonist | 0.302 0.171 DBMET00310 0.526 0.067 DBMET02586 0.25 0.215 DBMET02587 | DBMET02586 | |
| 0.035 | 0.075 | 0.072 | Argininosuccinate synthase inhibitor | 0.072 0.029 DBMET02587 | DBMET02587 | |
| 0.058 | 0.099 | 0.073 | Phosphodiesterase VI inhibitor | 0.071 0.059 DBMET00268 0.073 0.056 DBMET02587 | DBMET02587 | |
| 0.025 | 0.068 | 0.038 | Growth hormone release inhibitor | 0.038 0.035 DBMET00268 | DBMET00268 | |
| 0.101 | 0.144 | 0.298 | Mannose-6-phosphate isomerase inhibitor | 0.182 0.041 DBMET00268 0.298 0.005 DBMET02587 | DBMET02587 | |
| 0.06 | 0.104 | 0.102 | Potassium channel (Ca-activated) activator | 0.091 0.063 DBMET00268 0.085 0.069 DBMET00310 0.102 0.054 DBMET02587 | DBMET02587 | |
| 0.05 | 0.094 | 0.141 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.087 0.045 DBMET00268 0.07 0.061 DBMET00310 0.141 0.021 DBMET02587 | DBMET02587 | |
| 0.014 | 0.059 | 0.053 | Sodium/glucose cotransporter 2 inhibitor | 0.053 0.006 DBMET02586 0.027 0.017 DBMET02587 | DBMET02586 | |
| 0.046 | 0.091 | 0.076 | Leukotriene C antagonist | 0.054 0.047 DBMET00268 0.076 0.01 DBMET02587 | DBMET02587 | |
| 0.016 | 0.064 | 0.047 | Sodium/glucose cotransporter inhibitor | 0.047 0.005 DBMET02586 0.024 0.021 DBMET02587 | DBMET02586 | |
| 0.01 | 0.058 | 0.027 | Somatostatin 5 antagonist | 0.027 0.025 DBMET00268 | DBMET00268 | |
| 0.022 | 0.071 | 0.036 | Thiazolidinedione | 0.036 0.011 DBMET02587 | DBMET02587 | |
| 0.012 | 0.062 | 0.025 | Lysophosphatidic acid 1 receptor antagonist | 0.025 0.01 DBMET02587 | DBMET02587 | |
| 0.014 | 0.064 | 0.035 | Sirtuin 2 inhibitor | 0.035 0.021 DBMET00268 | DBMET00268 | |
| 0.102 | 0.152 | 0.132 | Sphingosine 1-phosphate receptor 2 antagonist | 0.132 0.071 DBMET02587 | DBMET02587 | |
| 0.096 | 0.147 | 0.208 | Cell wall synthesis inhibitor | 0.141 0.074 DBMET00268 0.208 0.027 DBMET02586 0.17 0.047 DBMET02587 | DBMET02586 | |
| 0.012 | 0.063 | 0.051 | Uridine phosphorylase inhibitor | 0.051 0.008 DBMET00268 0.04 0.012 DBMET02587 | DBMET00268 | |
| 0.016 | 0.069 | 0.026 | Thyroid hormone agonist | 0.026 0.018 DBMET02587 | DBMET02587 | |
| 0.015 | 0.068 | 0.124 | Peroxisome proliferator-activated receptor delta agonist | 0.124 0.005 DBMET02587 | DBMET02587 | |
| 0.019 | 0.072 | 0.046 | Diamine oxidase inhibitor | 0.046 0.018 DBMET00268 | DBMET00268 | |
| 0.016 | 0.069 | 0.024 | Glutamate (mGluR1) agonist | 0.024 0.019 DBMET02587 | DBMET02587 | |
| 0.023 | 0.077 | 0.05 | Dopamine D5 agonist | 0.05 0.017 DBMET00268 | DBMET00268 | |
| 0.072 | 0.128 | 0.131 | Toll-Like receptor 3 antagonist | 0.131 0.022 DBMET00268 | DBMET00268 | |
| 0.022 | 0.078 | 0.142 | Peroxisome proliferator-activated receptor alpha agonist | 0.142 0.007 DBMET02587 | DBMET02587 | |
| 0.082 | 0.139 | 0.139 | Cytokine production inhibitor | 0.123 0.087 DBMET00268 0.139 0.071 DBMET02587 | DBMET02587 | |
| 0.031 | 0.088 | 0.076 | Glutamate (mGluR group III) antagonist | 0.053 0.017 DBMET00268 0.076 0.008 DBMET02587 | DBMET02587 | |
| 0.059 | 0.117 | 0.074 | Sphingosine 1-phosphate receptor antagonist | 0.074 0.058 DBMET02587 | DBMET02587 | |
| 0.011 | 0.069 | 0.054 | Prostaglandin EP3 antagonist | 0.054 0.009 DBMET02587 | DBMET02587 | |
| 0.064 | 0.123 | 0.129 | Transcription factor NF kappa B stimulant | 0.129 0.021 DBMET02586 | DBMET02586 | |
| 0.087 | 0.146 | 0.135 | Interleukin 4 antagonist | 0.109 0.103 DBMET00268 0.133 0.067 DBMET00310 0.132 0.069 DBMET02586 0.135 0.066 DBMET02587 | DBMET02587 | |
| 0.105 | 0.165 | 0.342 | Nitric oxide antagonist | 0.137 0.108 DBMET00310 0.342 0.033 DBMET02586 0.145 0.099 DBMET02587 | DBMET02586 | |
| 0.029 | 0.09 | 0.047 | Kainate receptor agonist | 0.047 0.017 DBMET02587 | DBMET02587 | |
| 0.028 | 0.09 | 0.047 | Vanilloid 3 antagonist | 0.047 0.011 DBMET02587 | DBMET02587 | |
| 0.017 | 0.079 | 0.074 | Retinoid X alpha receptor agonist | 0.033 0.026 DBMET00268 0.074 0.008 DBMET02587 | DBMET02587 | |
| 0.01 | 0.073 | 0.044 | Leukotriene B4 receptor 1 antagonist | 0.044 0.009 DBMET02587 | DBMET02587 | |
| 0.028 | 0.092 | 0.038 | Glucagon-like peptide 1 receptor antagonist | 0.038 0.031 DBMET02587 | DBMET02587 | |
| 0.05 | 0.114 | 0.104 | GABA aminotransferase inhibitor | 0.104 0.024 DBMET00268 0.095 0.031 DBMET02587 | DBMET00268 | |
| 0.032 | 0.098 | 0.066 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.054 0.037 DBMET00268 0.066 0.024 DBMET02587 | DBMET02587 | |
| 0.064 | 0.13 | 0.224 | GABA C receptor agonist | 0.224 0.017 DBMET00268 0.188 0.023 DBMET02587 | DBMET00268 | |
| 0.027 | 0.093 | 0.042 | Microtubule stabilization | 0.042 0.039 DBMET02586 | DBMET02586 | |
| 0.013 | 0.08 | 0.09 | Retinoid X receptor agonist | 0.09 0.006 DBMET02587 | DBMET02587 | |
| 0.121 | 0.189 | 0.23 | Neurotrophic factor enhancer | 0.185 0.093 DBMET00268 0.23 0.051 DBMET02587 | DBMET02587 | |
| 0.068 | 0.137 | 0.149 | DNA polymerase I inhibitor | 0.106 0.08 DBMET00268 0.105 0.08 DBMET00310 0.149 0.05 DBMET02586 0.136 0.057 DBMET02587 | DBMET02586 | |
| 0.056 | 0.126 | 0.078 | Estrogen receptor alpha antagonist | 0.078 0.052 DBMET02587 | DBMET02587 | |
| 0.021 | 0.093 | 0.033 | Glutamate (mGluR3) agonist | 0.033 0.02 DBMET02587 | DBMET02587 | |
| 0.054 | 0.126 | 0.078 | MDM2 inhibitor | 0.078 0.023 DBMET02587 | DBMET02587 | |
| 0.035 | 0.108 | 0.176 | Antineoplastic antibiotic | 0.176 0.025 DBMET02586 0.103 0.045 DBMET02587 | DBMET02586 | |
| 0.019 | 0.092 | 0.162 | Peroxisome proliferator-activated receptor delta antagonist | 0.162 0.004 DBMET02587 | DBMET02587 | |
| 0.021 | 0.095 | 0.061 | Guanylate cyclase inhibitor | 0.047 0.024 DBMET00268 0.061 0.011 DBMET02587 | DBMET02587 | |
| 0.022 | 0.096 | 0.041 | Retinoic acid alpha receptor agonist | 0.041 0.024 DBMET02587 | DBMET02587 | |
| 0.038 | 0.113 | 0.074 | Purinergic P2X1 antagonist | 0.074 0.029 DBMET02587 | DBMET02587 | |
| 0.031 | 0.107 | 0.139 | Biliverdin reductase inhibitor | 0.082 0.025 DBMET00268 0.139 0.011 DBMET02587 | DBMET02587 | |
| 0.039 | 0.115 | 0.092 | Carbonic anhydrase XIII inhibitor | 0.092 0.042 DBMET00268 0.092 0.042 DBMET02587 | DBMET02587 | |
| 0.065 | 0.142 | 0.099 | Bile acid receptor antagonist | 0.099 0.052 DBMET02587 | DBMET02587 | |
| 0.028 | 0.105 | 0.049 | Leukotriene C4 antagonist | 0.049 0.011 DBMET02587 | DBMET02587 | |
| 0.02 | 0.097 | 0.056 | Phosphorylase inhibitor | 0.056 0.027 DBMET02586 0.043 0.035 DBMET02587 | DBMET02586 | |
| 0.005 | 0.083 | 0.017 | Prostaglandin EP1 antagonist | 0.017 0.016 DBMET02587 | DBMET02587 | |
| 0.104 | 0.182 | 0.158 | Sphingosine 1-phosphate receptor 5 antagonist | 0.145 0.069 DBMET00268 0.158 0.049 DBMET02587 | DBMET02587 | |
| 0.062 | 0.14 | 0.093 | Interleukin 5 antagonist | 0.079 0.075 DBMET00268 0.093 0.05 DBMET02587 | DBMET02587 | |
| 0.012 | 0.093 | 0.039 | Protein 30S ribosomal subunit inhibitor | 0.025 0.016 DBMET00268 0.039 0.01 DBMET02586 | DBMET02586 | |
| 0.062 | 0.145 | 0.108 | Lanosterol 14 alpha demethylase inhibitor | 0.108 0.044 DBMET00268 0.095 0.063 DBMET02587 | DBMET00268 | |
| 0.023 | 0.106 | 0.075 | Prostaglandin E2 antagonist | 0.075 0.021 DBMET02587 | DBMET02587 | |
| 0.016 | 0.1 | 0.062 | Vascular adhesion protein 1 inhibitor | 0.062 0.008 DBMET00268 | DBMET00268 | |
| 0.032 | 0.117 | 0.369 | Peroxisome proliferator-activated receptor gamma agonist | 0.369 0.004 DBMET02587 | DBMET02587 | |
| 0.017 | 0.104 | 0.055 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.037 0.019 DBMET00268 0.055 0.007 DBMET02587 | DBMET02587 | |
| 0.004 | 0.092 | 0.058 | Peroxisome proliferator-activated receptor alpha antagonist | 0.058 0.007 DBMET02587 | DBMET02587 | |
| 0.032 | 0.121 | 0.094 | Heparanase inhibitor | 0.094 0.004 DBMET02586 0.067 0.014 DBMET02587 | DBMET02586 | |
| 0.006 | 0.096 | 0.017 | Thromboxane A2 agonist | 0.017 0.009 DBMET02587 | DBMET02587 | |
| 0.046 | 0.138 | 0.206 | Monophenol monooxygenase inhibitor | 0.11 0.069 DBMET00268 0.206 0.032 DBMET02586 0.184 0.037 DBMET02587 | DBMET02586 | |
| 0.018 | 0.111 | 0.056 | Glutamate (mGluR3) antagonist | 0.04 0.021 DBMET00268 0.056 0.009 DBMET02587 | DBMET02587 | |
| 0.094 | 0.188 | 0.332 | Platelet adhesion inhibitor | 0.332 0.024 DBMET02586 0.139 0.119 DBMET02587 | DBMET02586 | |
| 0.011 | 0.105 | 0.022 | Retinoid X beta receptor antagonist | 0.022 0.011 DBMET02587 | DBMET02587 | |
| 0.039 | 0.134 | 0.086 | Adenine nucleotide translocase inhibitor | 0.086 0.007 DBMET02586 0.061 0.027 DBMET02587 | DBMET02586 | |
| 0.057 | 0.153 | 0.108 | MAO inhibitor | 0.108 0.083 DBMET00268 | DBMET00268 | |
| 0.014 | 0.111 | 0.06 | ATP citrate lysase inhibitor | 0.06 0.005 DBMET02587 | DBMET02587 | |
| 0.012 | 0.109 | 0.054 | Free fatty acid receptor 1 antagonist | 0.054 0.007 DBMET02587 | DBMET02587 | |
| 0.038 | 0.137 | 0.093 | MAO B inhibitor | 0.093 0.064 DBMET00268 | DBMET00268 | |
| 0.06 | 0.16 | 0.089 | Protein kinase C zeta inhibitor | 0.089 0.067 DBMET00268 | DBMET00268 | |
| 0.084 | 0.184 | 0.155 | Amyloid beta aggregation inhibitor | 0.152 0.106 DBMET00310 0.155 0.104 DBMET02586 | DBMET02586 | |
| 0.003 | 0.106 | 0.029 | G-protein-coupled receptor 120 agonist | 0.029 0.005 DBMET02587 | DBMET02587 | |
| 0.02 | 0.123 | 0.036 | Tryptophan 5 hydroxylase inhibitor | 0.036 0.025 DBMET02587 | DBMET02587 | |
| 0.06 | 0.164 | 0.176 | Xanthine oxidase inhibitor | 0.089 0.073 DBMET02586 0.176 0.025 DBMET02587 | DBMET02587 | |
| 0.05 | 0.154 | 0.249 | Protein-tyrosine phosphatase 1B inhibitor | 0.096 0.082 DBMET02586 0.249 0.017 DBMET02587 | DBMET02587 | |
| 0.046 | 0.151 | 0.082 | Glycine receptor agonist | 0.082 0.036 DBMET00268 0.082 0.036 DBMET02587 | DBMET02587 | |
| 0.096 | 0.202 | 0.383 | Hepatoprotectant | 0.132 0.131 DBMET00268 0.133 0.129 DBMET00310 0.383 0.015 DBMET02586 0.197 0.067 DBMET02587 | DBMET02586 | |
| 0.022 | 0.128 | 0.041 | Glutamate (mGluR8) agonist | 0.041 0.021 DBMET02587 | DBMET02587 | |
| 0.044 | 0.15 | 0.116 | Histamine N-methyltransferase inhibitor | 0.116 0.033 DBMET00268 | DBMET00268 | |
| 0.035 | 0.142 | 0.057 | NMDA receptor agonist | 0.057 0.052 DBMET02587 | DBMET02587 | |
| 0.106 | 0.215 | 0.439 | Free radical scavenger | 0.206 0.093 DBMET00310 0.439 0.023 DBMET02586 0.197 0.1 DBMET02587 | DBMET02586 | |
| 0.109 | 0.219 | 0.371 | Tumour necrosis factor alpha release inhibitor | 0.371 0.033 DBMET02586 | DBMET02586 | |
| 0.028 | 0.138 | 0.085 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.062 0.037 DBMET00268 0.085 0.022 DBMET02587 | DBMET02587 | |
| 0.02 | 0.13 | 0.049 | Retinoid X receptor antagonist | 0.049 0.013 DBMET02587 | DBMET02587 | |
| 0.086 | 0.197 | 0.13 | Heat shock protein 90 antagonist | 0.13 0.098 DBMET00310 | DBMET00310 | |
| 0.071 | 0.182 | 0.107 | Estrogen antagonist | 0.107 0.082 DBMET00310 0.104 0.088 DBMET02587 | DBMET00310 | |
| 0.097 | 0.21 | 0.167 | Anticonvulsant | 0.167 0.11 DBMET00268 | DBMET00268 | |
| 0.067 | 0.181 | 0.132 | DOPA decarboxylase inhibitor | 0.102 0.073 DBMET00268 0.132 0.033 DBMET02587 | DBMET02587 | |
| 0.099 | 0.215 | 0.136 | Antipruritic | 0.136 0.112 DBMET00268 | DBMET00268 | |
| 0.018 | 0.135 | 0.041 | Retinoid X alpha receptor antagonist | 0.041 0.014 DBMET02587 | DBMET02587 | |
| 0.019 | 0.137 | 0.042 | Liver X receptor alpha agonist | 0.042 0.028 DBMET02587 | DBMET02587 | |
| 0.029 | 0.148 | 0.083 | Leukotriene synthesis inhibitor | 0.083 0.036 DBMET02587 | DBMET02587 | |
| 0.032 | 0.154 | 0.073 | CDC25B inhibitor | 0.073 0.034 DBMET02587 | DBMET02587 | |
| 0.012 | 0.135 | 0.026 | Retinoid X gamma receptor antagonist | 0.026 0.021 DBMET02587 | DBMET02587 | |
| 0.056 | 0.181 | 0.115 | ABCA1 expression enhancer | 0.115 0.034 DBMET02587 | DBMET02587 | |
| 0.086 | 0.21 | 0.215 | Anesthetic general | 0.189 0.081 DBMET00268 0.215 0.067 DBMET02587 | DBMET02587 | |
| 0.013 | 0.137 | 0.045 | Purinergic P2Y antagonist | 0.045 0.031 DBMET02587 | DBMET02587 | |
| 0.048 | 0.173 | 0.105 | Cell adhesion molecule inhibitor | 0.105 0.031 DBMET02586 0.084 0.049 DBMET02587 | DBMET02586 | |
| 0.028 | 0.153 | 0.052 | Topoisomerase II beta inhibitor | 0.052 0.03 DBMET02587 | DBMET02587 | |
| 0.034 | 0.16 | 0.068 | DNA helicase inhibitor | 0.068 0.018 DBMET02587 | DBMET02587 | |
| 0.016 | 0.145 | 0.034 | Toll-Like receptor 4 agonist | 0.034 0.008 DBMET02586 | DBMET02586 | |
| 0.011 | 0.141 | 0.037 | Farnesoid X receptor agonist | 0.037 0.028 DBMET02587 | DBMET02587 | |
| 0.039 | 0.17 | 0.078 | Myeloperoxidase inhibitor | 0.078 0.07 DBMET00268 | DBMET00268 | |
| 0.056 | 0.189 | 0.125 | Protein kinase C gamma inhibitor | 0.125 0.049 DBMET00268 | DBMET00268 | |
| 0.022 | 0.155 | 0.052 | Diacylglycerol O-acyltransferase inhibitor | 0.052 0.034 DBMET02587 | DBMET02587 | |
| 0.033 | 0.168 | 0.102 | CYP2A6 inhibitor | 0.102 0.035 DBMET00268 | DBMET00268 | |
| 0.04 | 0.175 | 0.172 | Topoisomerase I inhibitor | 0.093 0.076 DBMET00268 0.172 0.034 DBMET02586 | DBMET02586 | |
| 0.035 | 0.171 | 0.065 | Histone deacetylase stimulant | 0.065 0.061 DBMET02587 | DBMET02587 | |
| 0.035 | 0.171 | 0.065 | Histone deacetylase SIRT1 stimulant | 0.065 0.061 DBMET02587 | DBMET02587 | |
| 0.068 | 0.204 | 0.181 | Cell adhesion inhibitor | 0.181 0.031 DBMET02586 0.122 0.064 DBMET02587 | DBMET02586 | |
| 0.004 | 0.141 | 0.022 | Free fatty acid receptor 1 agonist | 0.022 0.009 DBMET02587 | DBMET02587 | |
| 0.057 | 0.194 | 0.087 | D-Ala-D-Ala ligase inhibitor | 0.079 0.073 DBMET00268 0.087 0.051 DBMET02587 | DBMET02587 | |
| 0.154 | 0.292 | 0.566 | Antibacterial | 0.333 0.112 DBMET00268 0.219 0.208 DBMET00310 0.566 0.025 DBMET02586 0.235 0.192 DBMET02587 | DBMET02586 | |
| 0.079 | 0.218 | 0.185 | Hexokinase inhibitor | 0.153 0.075 DBMET00268 0.131 0.103 DBMET02586 0.185 0.045 DBMET02587 | DBMET02587 | |
| 0.016 | 0.158 | 0.091 | Xanthine dehydrogenase inhibitor | 0.091 0.019 DBMET02587 | DBMET02587 | |
| 0.028 | 0.171 | 0.058 | Thromboxane synthase inhibitor | 0.058 0.03 DBMET02587 | DBMET02587 | |
| 0.033 | 0.177 | 0.057 | Pregnane X receptor antagonist | 0.057 0.037 DBMET02587 | DBMET02587 | |
| 0.041 | 0.187 | 0.093 | Urease inhibitor | 0.093 0.074 DBMET00268 | DBMET00268 | |
| 0.069 | 0.215 | 0.298 | Protein-tyrosine phosphatase inhibitor | 0.298 0.019 DBMET02587 | DBMET02587 | |
| 0.037 | 0.185 | 0.082 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.082 0.033 DBMET00268 | DBMET00268 | |
| 0.027 | 0.176 | 0.123 | Porphobilinogen synthase inhibitor | 0.101 0.035 DBMET00268 0.123 0.027 DBMET02587 | DBMET02587 | |
| 0.026 | 0.176 | 0.067 | Factor IXa inhibitor | 0.067 0.022 DBMET02586 | DBMET02586 | |
| 0.035 | 0.187 | 0.074 | CDC25A inhibitor | 0.074 0.05 DBMET02587 | DBMET02587 | |
| 0.015 | 0.167 | 0.159 | Prostaglandin antagonist | 0.159 0.009 DBMET02587 | DBMET02587 | |
| 0.107 | 0.26 | 0.166 | Catenin beta inhibitor | 0.166 0.072 DBMET02587 | DBMET02587 | |
| 0.111 | 0.267 | 0.133 | Heat shock protein 70 antagonist | 0.131 0.116 DBMET00268 0.133 0.106 DBMET02587 | DBMET02587 | |
| 0.062 | 0.22 | 0.115 | TRPA1 agonist | 0.096 0.095 DBMET00268 0.115 0.064 DBMET02587 | DBMET02587 | |
| 0.127 | 0.287 | 0.389 | Immunomodulator | 0.389 0.047 DBMET02586 | DBMET02586 | |
| 0.023 | 0.185 | 0.076 | HIV-1 integrase (3'-Processing) inhibitor | 0.076 0.035 DBMET02587 | DBMET02587 | |
| 0.091 | 0.255 | 0.16 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.16 0.131 DBMET00268 | DBMET00268 | |
| 0.088 | 0.253 | 0.14 | CF transmembrane conductance regulator agonist | 0.14 0.094 DBMET00268 0.13 0.119 DBMET02587 | DBMET00268 | |
| 0.028 | 0.194 | 0.042 | Heme oxygenase inhibitor | 0.042 0.033 DBMET02587 | DBMET02587 | |
| 0.006 | 0.179 | 0.029 | Leukotriene D4 antagonist | 0.029 0.016 DBMET02587 | DBMET02587 | |
| 0.032 | 0.206 | 0.087 | Glutamate (mGluR7) antagonist | 0.087 0.02 DBMET02587 | DBMET02587 | |
| 0.016 | 0.191 | 0.13 | Plasminogen activator inhibitor antagonist | 0.13 0.006 DBMET02587 | DBMET02587 | |
| 0.037 | 0.217 | 0.077 | Exportin-1 inhibitor | 0.069 0.045 DBMET00268 0.077 0.029 DBMET02587 | DBMET02587 | |
| 0.037 | 0.218 | 0.057 | Lipocortins synthesis agonist | 0.057 0.042 DBMET02586 | DBMET02586 | |
| 0.043 | 0.225 | 0.095 | Nitric-oxide synthase inhibitor | 0.095 0.068 DBMET00268 | DBMET00268 | |
| 0.017 | 0.203 | 0.091 | Protein 50S ribosomal subunit inhibitor | 0.091 0.016 DBMET02586 | DBMET02586 | |
| 0.04 | 0.227 | 0.15 | HIV-1 integrase (Overall Integration) inhibitor | 0.104 0.051 DBMET00268 0.15 0.025 DBMET02587 | DBMET02587 | |
| 0.06 | 0.252 | 0.201 | Anticoagulant | 0.201 0.052 DBMET02586 | DBMET02586 | |
| 0.084 | 0.277 | 0.134 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.134 0.105 DBMET00268 | DBMET00268 | |
| 0.016 | 0.211 | 0.066 | NMDA receptor glycine site agonist | 0.066 0.039 DBMET02587 | DBMET02587 | |
| 0.004 | 0.202 | 0.043 | Prostaglandin D2 antagonist | 0.043 0.008 DBMET02587 | DBMET02587 | |
| 0.097 | 0.296 | 0.242 | Lipoxygenase inhibitor | 0.178 0.166 DBMET00268 0.242 0.106 DBMET02587 | DBMET02587 | |
| 0.023 | 0.23 | 0.06 | Glucose-6-phosphate translocase inhibitor | 0.06 0.024 DBMET02586 | DBMET02586 | |
| 0.005 | 0.215 | 0.028 | Endothelin receptor antagonist | 0.028 0.019 DBMET02587 | DBMET02587 | |
| 0.038 | 0.252 | 0.146 | Ferrochelatase inhibitor | 0.146 0.04 DBMET02587 | DBMET02587 | |
| 0.036 | 0.273 | 0.103 | 5 Hydroxytryptamine 3A agonist | 0.103 0.072 DBMET00268 | DBMET00268 | |
| 0.026 | 0.272 | 0.091 | 5-Lipoxygenase inhibitor | 0.091 0.071 DBMET02587 | DBMET02587 | |
| 0.07 | 0.316 | 0.249 | Non-steroidal antiinflammatory agent | 0.249 0.043 DBMET02587 | DBMET02587 | |
| 0.048 | 0.296 | 0.233 | Pyruvate kinase inhibitor | 0.233 0.066 DBMET02587 | DBMET02587 | |
| 0.081 | 0.333 | 0.162 | Lipocortins synthesis antagonist | 0.162 0.089 DBMET02587 | DBMET02587 | |
| 0.011 | 0.264 | 0.069 | HIV-1 integrase (Strand Transfer) inhibitor | 0.069 0.036 DBMET02587 | DBMET02587 | |
| 0.004 | 0.264 | 0.042 | Kynurenine 3 monooxygenase inhibitor | 0.042 0.009 DBMET02587 | DBMET02587 | |
| 0.01 | 0.272 | 0.054 | Aldose reductase inhibitor | 0.054 0.036 DBMET02587 | DBMET02587 | |
| 0.024 | 0.306 | 0.075 | HIV-1 integrase inhibitor | 0.075 0.042 DBMET02587 | DBMET02587 | |
| 0.024 | 0.313 | 0.074 | Macrophage migration inhibitory factor inhibitor | 0.074 0.06 DBMET02587 | DBMET02587 | |
| 0.085 | 0.387 | 0.208 | 15-Lipoxygenase inhibitor | 0.208 0.205 DBMET00268 | DBMET00268 | |
| 0.03 | 0.338 | 0.105 | Uric acid excretion stimulant | 0.105 0.048 DBMET02587 | DBMET02587 | |
| 0.066 | 0.393 | 0.295 | Alpha-glucosidase inhibitor | 0.295 0.162 DBMET02586 | DBMET02586 | |
| 0.03 | 0.362 | 0.101 | Beta glucuronidase inhibitor | 0.101 0.068 DBMET02586 | DBMET02586 | |
| 0.032 | 0.371 | 0.163 | Mcl-1 antagonist | 0.163 0.078 DBMET02587 | DBMET02587 | |
| 0.069 | 0.453 | 0.154 | Growth factor agonist | 0.154 0.132 DBMET00268 | DBMET00268 | |
| 0.039 | 0.465 | 0.174 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.174 0.093 DBMET00268 | DBMET00268 | |
| 0.017 | 0.466 | 0.17 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.17 0.055 DBMET00268 | DBMET00268 | |
| 0.081 | 0.531 | 0.131 | CC chemokine 6 receptor antagonist | 0.131 0.069 DBMET02586 | DBMET02586 | |
| 0.018 | 0.487 | 0.121 | Protein kinase C nu inhibitor | 0.121 0.091 DBMET00268 | DBMET00268 | |
| 0.02 | 0.493 | 0.19 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.19 0.069 DBMET00268 | DBMET00268 | |
| 0.019 | 0.505 | 0.167 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.167 0.104 DBMET00268 | DBMET00268 | |
| 0.037 | 0.615 | 0.147 | NOS3 expression enhancer | 0.147 0.076 DBMET02586 | DBMET02586 | |
| 0.043 | 0.711 | 0.533 | Antiinflammatory | 0.533 0.074 DBMET02586 | DBMET02586 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |